成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one

3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one Struktur
61532-36-3
CAS-Nr.
61532-36-3
Englisch Name:
3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one
Synonyma:
3-methyl-1H-imidazo[4,5-c]pyridin-2-one;3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one;2H-Imidazo[4,5-c]pyridin-2-one, 1,3-dihydro-3-methyl-
CBNumber:
CB04891253
Summenformel:
C7H7N3O
Molgewicht:
149.15
MOL-Datei:
61532-36-3.mol

3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one Eigenschaften

Schmelzpunkt:
259-260 °C(Solv: ethanol (64-17-5))
Dichte
1.293±0.06 g/cm3(Predicted)
pka
12.20±0.20(Predicted)

Sicherheit

3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BioPharmaMatrix,Inc. 0510-86010668
sales@biopharmamatrix.com China 4208 55
Shanghai Anmike Chemical Co. Ltd. 18019252918
sale@amkchem.com China 7321 55
Aikon International Limited 025-58851090 13611564524
lwan@aikonchem.com China 15951 58
Shanghai Kaiwei Chemical Technology Co., Ltd. 021-58461859 15821823057
service@aiviche.com China 49312 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
malulu@leyan.com China 54987 58
Hebei Weite Medical Technology Co., Ltd 13180081292
contact@wetogethermed.com China 7529 58
Bide Pharmatech Ltd. 400-1647117 13681763483
product02@bidepharm.com China 62075 58
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 17801761073
Gsiyu@solarbio.com China 50464 58

  • 3-Methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one
  • 2H-Imidazo[4,5-c]pyridin-2-one, 1,3-dihydro-3-methyl-
  • 3-methyl-1H-imidazo[4,5-c]pyridin-2-one
  • 61532-36-3
Copyright 2019 ? ChemicalBook. All rights reserved